ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name "ANG Lifesciences India Private Limited" on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to "ANG Lifesciences India Private Limited" on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to "ANG Lifesciences India Limited" on May 18, 2016.
The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 2008-09, the Company started its commercial production. In 2014-15, it commenced direct sale of medicines covering hospitals , Doctors through stockists.
The Company is ISO-9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum & Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing set-up consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. Its diversified product range covers multiple dosage forms, including dry powder injections, tablets, hard gelatin capsules, liquid syrups, liquid injections (ampoules/vials), and pre-filled syringes (PFS).
In August, 2017, the Company came up with a Public Issue of 15,00,800 Equity Shares by raising money from public aggregating to Rs 12 Crore.
The Company acquired Mansa Printers & Publishers Limited in April, 2021 for backward integration in pharma packaging to optimize costs and ensure timely availability of packaging products.
ANG Lifesciences India share price as on 02 Mar 2026 is Rs. 23.17. Over the past 6 months, the ANG Lifesciences India share price has decreased by 20.43% and in the last one year, it has decreased by 33.21%. The 52-week low for ANG Lifesciences India share price was Rs. 21.03 and 52-week high was Rs. 39.7.
ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name "ANG Lifesciences India Private Limited" on June 14, 2006. On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010. The Company further converted into Private Limited Company and the name of the Company was changed to "ANG Lifesciences India Private Limited" on September 22, 2010. Subsequently, on conversion into Public Limited Company, the name again changed to "ANG Lifesciences India Limited" on May 18, 2016.
The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials. In 2008-09, the Company started its commercial production. In 2014-15, it commenced direct sale of medicines covering hospitals , Doctors through stockists.
The Company is ISO-9001:2008 certified, which manufacture its products in compliance with GMP requirements. Company has dedicated area, machinery, facilities and advanced equipment for manufacturing of Beta Lactum & Non Beta Lactum products as per GMP norms. The Company currently operates a strong manufacturing set-up consisting of 4 formulation plants situated at Baddi, Himachal Pradesh. Its diversified product range covers multiple dosage forms, including dry powder injections, tablets, hard gelatin capsules, liquid syrups, liquid injections (ampoules/vials), and pre-filled syringes (PFS).
In August, 2017, the Company came up with a Public Issue of 15,00,800 Equity Shares by raising money from public aggregating to Rs 12 Crore.
The Company acquired Mansa Printers & Publishers Limited in April, 2021 for backward integration in pharma packaging to optimize costs and ensure timely availability of packaging products.
ANG Lifesciences India share price as on 02 Mar 2026 is Rs. 23.17. Over the past 6 months, the ANG Lifesciences India share price has decreased by 20.43% and in the last one year, it has decreased by 33.21%. The 52-week low for ANG Lifesciences India share price was Rs. 21.03 and 52-week high was Rs. 39.7.
